Matthew Day - Roth CH CoChief Officer
| ROCL Stock | USD 11.32 0.03 0.27% |
Insider
Matthew Day is CoChief Officer of Roth CH Acquisition
| Address | 888 San Clemente Drive, Newport Beach, CA, United States, 92660 |
| Phone | 949 720 5700 |
| Web | https://rocl.rothch.com |
Matthew Day Latest Insider Activity
Tracking and analyzing the buying and selling activities of Matthew Day against Roth CH stock is an integral part of due diligence when investing in Roth CH. Matthew Day insider activity provides valuable insight into whether Roth CH is net buyers or sellers over its current business cycle. Note, Roth CH insiders must abide by specific rules, including filing SEC forms every time they buy or sell Roth CH'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Matthew Day over three months ago Disposition of tradable shares by Matthew Day of Roth CH subject to Rule 16b-3 |
Roth CH Management Efficiency
The company has return on total asset (ROA) of (0.0708) % which means that it has lost $0.0708 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 2.0232 %, meaning that it created $2.0232 on every $100 dollars invested by stockholders. Roth CH's management efficiency ratios could be used to measure how well Roth CH manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.0053. Return On Capital Employed is expected to rise to -0.12 this year. The value of Total Assets is estimated to slide to about 16.4 M. The value of Net Tangible Assets is estimated to slide to about 689.7 KSimilar Executives
| Showing other executives | INSIDER Age | ||
| Joe McCabe | SEI Investments | N/A | |
| Anne Pascard | ABIVAX Socit Anonyme | N/A | |
| Raquel Lizarraga | ABIVAX Socit Anonyme | N/A | |
| Julia Jordan | Goosehead Insurance | N/A | |
| Patrick Langston | Goosehead Insurance | 42 | |
| Ann Challis | Goosehead Insurance | N/A | |
| Leslie Wojcik | SEI Investments | N/A | |
| Pierre MBA | ABIVAX Socit Anonyme | N/A | |
| Regina Jehle | ABIVAX Socit Anonyme | N/A | |
| Prof Ehrlich | ABIVAX Socit Anonyme | N/A | |
| James Smigiel | SEI Investments | 55 | |
| Philippe MD | ABIVAX Socit Anonyme | 65 | |
| Paul Gineste | ABIVAX Socit Anonyme | N/A | |
| Jose Teixeira | Patria Latin American | 45 | |
| Marco DIppolito | Patria Latin American | 47 | |
| Alain Chevallier | ABIVAX Socit Anonyme | 70 | |
| Jared Sinclair | Goosehead Insurance | N/A | |
Management Performance
| Return On Equity | 2.02 | ||||
| Return On Asset | -0.0708 |
Roth CH Acquisition Leadership Team
Elected by the shareholders, the Roth CH's board of directors comprises two types of representatives: Roth CH inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Roth. The board's role is to monitor Roth CH's management team and ensure that shareholders' interests are well served. Roth CH's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Roth CH's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Costa, CoChief Officer | ||
| Matthew Day, CoChief Officer | ||
| Ryan Hultstrand, CoChief Officer | ||
| Joseph Tonnos, Chief Officer | ||
| John Lipman, CoCEO CoChairman | ||
| Gordon CPA, Chief Officer | ||
| Byron BBA, CoCEO CoChairman | ||
| Aaron Gurewitz, CoPresident | ||
| William Hartfiel, CoPresident |
Roth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Roth CH a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 2.02 | ||||
| Return On Asset | -0.0708 | ||||
| Current Valuation | 56.82 M | ||||
| Shares Outstanding | 4.92 M | ||||
| Shares Owned By Insiders | 66.22 % | ||||
| Shares Owned By Institutions | 34.68 % | ||||
| Number Of Shares Shorted | 9.96 K | ||||
| Price To Book | 4.11 X | ||||
| EBITDA | (582.13 K) | ||||
| Net Income | (3.16 M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roth CH Acquisition. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Roth CH. If investors know Roth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Roth CH listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 10.072 | Earnings Share (0.38) | Return On Assets (0.07) | Return On Equity 2.0232 |
The market value of Roth CH Acquisition is measured differently than its book value, which is the value of Roth that is recorded on the company's balance sheet. Investors also form their own opinion of Roth CH's value that differs from its market value or its book value, called intrinsic value, which is Roth CH's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Roth CH's market value can be influenced by many factors that don't directly affect Roth CH's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Roth CH's value and its price as these two are different measures arrived at by different means. Investors typically determine if Roth CH is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Roth CH's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.